Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2020

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #1702

    Har tjekket historien. Ingen døde, men oplevede voldsomme bivirkninger som var livstruende.

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #1703

      Forsøget medførte at Torben Plesner og Genmab var ekstremt forsigtige med doseringen da man startede forsøg op med daratumumab.

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #1704

        God morgen 🙂

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #1705

          Community advice : SQ formulation of Daratumumab. ( transscript ) https://www.onclive.com/insights/daratumumab-subcutaneous-formulation-for-treatment-of-mm?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

          1 Reply Last reply
          0
          • T Offline
            T Offline
            transalp
            wrote on sidst redigeret af
            #1706

            Go morgen .. 🙂

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #1707

              GMAB US lukkede i + 10 ( +0,30 % ). 🙂

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #1708

                God morgen;-)

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #1709

                  God morgen. 🙂

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #1710

                    Nikkei 225 i Tokyo faller 1,33 prosent
                    Kospi i Seoul faller 1,70 prosent
                    Singapore-børsen er ned 1,17 prosent
                    ASX 200 i Sydney faller 1,63 prosent

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #1711

                      Nogen der kender denne Halozymes klon?

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #1712

                        Just a moment...

                        favicon

                        (www.firstwordpharma.com)

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1713

                          @Solsen / Helge , Sanofi is already working on a trispecific CD3, CD28, and CD38

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #1714

                            Credit Suisse sænker kursmål til DKK 2.235 fra DKK 2.300 og ændrer anbefaling til ’Neutral’ fra ’Outperform’

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #1715

                              well, ok, but UBS Reiterates Buy Rating on Genmab A/S (GEN:DC) (GMAB) 😉

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GeorgeBest
                                wrote on sidst redigeret af
                                #1716

                                ** Credit Suisse downgrades Danish pharmaceutical company Genmab GMAB.CO to "neutral" from "outperform" after it had found a material error in the PharmaValues net present value (NPV) calculation for the company
                                ** Due to the error, the value of cancer drug Darzalex and chronic lymphocytic leukemia antibody ofatumumab royalties to Genmab were overstated, the brokerage says
                                ** CS says its revised Genmab PharmaValues Equity NPV is DKK 1,800/share, reduced from DKK2,300/share seen previously

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  GeorgeBest
                                  wrote on sidst redigeret af
                                  #1717

                                  ** However, the error did not impact the broker's revenue or earnings model assumptions
                                  ** CS cuts it target price to DKK 2,235 from DKK 2,300 using the average Biotech and Specialty Pharma EV/NPV premium of 30%
                                  ** Following significant stock performance in H1 2020, the broker sees more limited near-term upside
                                  ** It still sees ofatumumab sales by partner Novartis NOVN.S as underappreciated
                                  ** It expects more modest further catalysts in H2 2020 following the positive AbbVie's ABBV.N oncology pa

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    GeorgeBest
                                    wrote on sidst redigeret af
                                    #1718

                                    partnership with Genmab and epcoritamab data

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      kkjoel
                                      wrote on sidst redigeret af
                                      #1719

                                      Tak, GB 🙂

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #1720

                                        bizarre...

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #1721

                                          Community Advice: SQ Formulation of Daratumumab https://www.youtube.com/watch?v=nuL179KaL5U

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger